From: A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
Variable
HR (95%CI)
p-Value
Cinacalcet
1.13 (0.39–3.2)
0.82
Age at baseline
1.07 (1.02–1.13)
0.013
Gender (Male)
2.71 (0.99–7.3)
0.05
Ethnicity (Caucasian)
2.3 (0.05–11.3)
0.47
Smoking at baseline
0.86 (0.29–2.5)
0.78